AnaCardio, a Swedish clinical-stage biopharmaceutical company focusing on developing novel drugs to treat patients with heart failure, has appointed Philipp Mathieu as CFO. Mathieu is an experienced healthcare executive with…
Sweden: AnaCardio strengthens leadership team with appointment of Philipp Mathieu as CFO
…
…






